TIDES: Oligonucleotide and Peptide Therapeutics

TIDES: Oligonucleotide and Peptide Therapeutics is an event that consists of two conference EuroTides and EuroPeptides, covering clinical, manufacturing and R&D developments for RNAi, miRNA, Antisense, Aptamers and Peptides.

TIDES: Oligonucleotide and Peptide Therapeutics covers topics such as:

• GalNAc-conjugated siRNAs as a new paradigm in oligonucleotide therapeutics
• Critical feedback on the current status and future developments of antisense technology
• Strategies to overcome the delivery and manufacturing challenges for mRNA therapeutics
• Novel strategies to improve the delivery of oligonucleotides to the liver and beyond
• The future of oligonucleotides and the potential of emerging new silencing technologies
• Best practises for the manufacture, analytical and process considerations for oligonucleotide therapeutics
• Formulation strategies and the most successful technologies for sustained release of your peptide product
• Pre-clinical and clinical programmes with case studies insights
• Processes to optimise peptide synthesis and large scale peptide manufacturing
• Developments in non-invasive delivery methods including recent developments in orally bioavailable peptides
• Advances in analytical strategies and tools for characterising impurities and understanding metabolism of peptide drug candidates
• The application of microwave synthesisers to scale up peptide production
• Methodologies to increase the half-life, stability and retention rates of peptide products

TIDES: Oligonucleotide and Peptide Therapeutics brings together attendees involved or interested in:

• RNA
• Oligonucleotides
• Antisense
• RNA Therapeutics
• R&D
• MRNA
• Drug Substance Manufacturing
• Oligonucleotide Manufacturing
• API Development
• Process Development / Process Optimisation
• CMC
• Process Chemistry
• Drug Delivery
• Drug Development
• Analytical Development
• Drug Discovery
• Clinical Development
• Formulation
• Pharmaceutical Development / Product Development / Technical Development
• Preclinical
• Peptides
• Quality Assurance / Quality Control
• Process Development / Process Optimisation
• Peptide Manufacturing
• Process Chemistrt
• API Development
• Peptides CMC and Engineering
• Peptide Chemist
• Peptide Drug Delivery
• Peptide Drug Development
• Formulation
• Analytical Development
• Preclinical R&D
• Clinical Development
• Regulatory
• Pharmaceutical Development
• Quality Assurance / Quality Control

TIDES: Oligonucleotide and Peptide Therapeutics will be held in Long Beach, CA, United States on 10-13 May 2021.